Matrix Capital Management Company, LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 14, 2026), Matrix Capital Management Company, LP reported 1 stock position worth $46.3 million. Its top holding was Aura Biosciences (AURA) at 100.0% of the portfolio. Compared with Q4 2025, it sold out of 1. The biggest sale was an exit from Maze Therapeutics (MAZE).
- Most Recent 13F
- Q2 2026
- Location
- Portsmouth, NH
- CIK
- 0001410830
- Portfolio Value
- $46.3M (Q1 2026)
- SEC Filing
- 0001172661-26-001967 ↗ filed May 14, 2026
Holdings Value
Holdings 1 stocks · $46.3M
| AURA Aura Biosciences Inc. | 100.00% | 6,922,870 | $46.3M | No change |
Portfolio Sells Q4 2025 → Q1 2026
| MAZE Maze Therapeutics Inc. | Sold out | 0.00% | −34.52 |
Portfolio Buys Q4 2025 → Q1 2026
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 1 | $46.3M | AURA |
| Q4 2025 | 2 | $57.6M | AURA, MAZE |
| Q3 2025 | 3 | $106.7M | MAZE, AURA, ZNTL |
| Q2 2025 | 4 | $222.8M | GFS, AURA, MAZE, ZNTL |
| Q1 2025 | 4 | $347.2M | GFS, AURA, MAZE, ZNTL |
| Q4 2024 | 5 | $2.2B | ALTR, GFS, PRM, AURA, ZNTL |
| Q3 2024 | 7 | $2.1B | ALTR, GFS, PRM, AURA, ZNTL |
| Q2 2024 | 23 | $13.1B | NVDA, QCOM, TDG, ALTR, MRVL |
| Q1 2024 | 23 | $10.8B | NVDA, TDG, QCOM, ALTR, MRVL |